IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
Dec 17, 2010 4:30pm EST

Immunovaccine Grants Stock Options

Dec 14, 2010 4:36pm EST

Immunovaccine Announces Preliminary Safety Results from Phase I Clinical Trial of DPX-0907 Cancer Vaccine

Dec 06, 2010 5:30pm EST

Immunovaccine Announces Issuance of Common Shares to a Consultant

Dec 02, 2010 9:17am EST

Invitation-Immunovaccine Inc. Investor Reception

Nov 29, 2010 6:30pm EST

Immunovaccine Signs Research Agreement with OncoTherapy Science to Advance Potential Cancer Vaccine

Nov 24, 2010 4:34pm EST

Immunovaccine Announces 2010 Third Quarter Results

Nov 17, 2010 5:43am EST

Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer

Nov 08, 2010 3:37pm EST

Immunovaccine Inc. Successfully Formulates Cel-Sci's CEL-2000 Rheumatoid Arthritis Vaccine in DepoVax(TM)

Oct 18, 2010 8:28am EDT

Immunovaccine Signs Agreement With National Research Council to Evaluate Carbohydrate-Based Vaccine

Oct 13, 2010 7:48pm EDT

Immunovaccine Inc. and Defence Research and Development Canada Advance Potential Melioidosis Vaccine Candidate

RSS
  • Prev
  • 1...
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap